1218 related articles for article (PubMed ID: 27620662)
1. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.
Fan J; Liu D; He C; Li X; He F
J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662
[TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.
Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L
J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754
[TBL] [Abstract][Full Text] [Related]
3. Triptolide-induced hepatotoxicity can be alleviated when combined with Panax notoginseng saponins and Catapol.
Zhou L; Zhou C; Feng Z; Liu Z; Zhu H; Zhou X
J Ethnopharmacol; 2018 Mar; 214():232-239. PubMed ID: 29277608
[TBL] [Abstract][Full Text] [Related]
4. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression.
Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT
J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903
[TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y
J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337
[TBL] [Abstract][Full Text] [Related]
6. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
7. Panax notoginseng saponins ameliorate impaired arterial vasodilation in SHRSP.Z-Lepr(fa) /lzmDmcr rats with metabolic syndrome.
Wu T; Sun J; Kagota S; Maruyama K; Wakuda H; Shinozuka K
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):459-67. PubMed ID: 26784885
[TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway.
Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326
[TBL] [Abstract][Full Text] [Related]
9.
Hu S; Wu Y; Zhao B; Hu H; Zhu B; Sun Z; Li P; Du S
Molecules; 2018 Oct; 23(11):. PubMed ID: 30373188
[TBL] [Abstract][Full Text] [Related]
10. Panax notoginseng saponins suppress lipopolysaccharide-induced barrier disruption and monocyte adhesion on bEnd.3 cells via the opposite modulation of Nrf2 antioxidant and NF-κB inflammatory pathways.
Hu S; Liu T; Wu Y; Yang W; Hu S; Sun Z; Li P; Du S
Phytother Res; 2019 Dec; 33(12):3163-3176. PubMed ID: 31468630
[TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action.
Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019
[TBL] [Abstract][Full Text] [Related]
12. [Advances in pharmacological studies of Panax notoginseng saponins on brain ischemia-reperfusion injury].
Yang PF; Song XY; Chen NH
Yao Xue Xue Bao; 2016 Jul; 51(7):1039-46. PubMed ID: 29896950
[TBL] [Abstract][Full Text] [Related]
13. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice.
Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J
Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987
[TBL] [Abstract][Full Text] [Related]
14. Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro.
Wang MM; Xue M; Xu YG; Miao Y; Kou N; Yang L; Zhang Y; Shi DZ
Thromb Res; 2016 May; 141():146-52. PubMed ID: 27043068
[TBL] [Abstract][Full Text] [Related]
15. Panax notoginseng Saponins protect auditory cells against cisplatin‑induced ototoxicity by inducing the AKT/Nrf2 signaling‑mediated redox pathway.
Fei B; Liu Z; Xie L; Lv L; Zhu W; Liu J; Dai Y; She W
Mol Med Rep; 2020 Oct; 22(4):3533-3540. PubMed ID: 32945421
[TBL] [Abstract][Full Text] [Related]
16. [Effects of panax notoginseng saponins on expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells injury induced by oxidized low-density lipoprotein].
Qin JH; Zhu LQ; Cui W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Dec; 28(12):1096-9. PubMed ID: 19317166
[TBL] [Abstract][Full Text] [Related]
17. [Major hypoglycemic ingredients of Panax notoginseng saponins for treating diabetes].
Zhong ZD; Wang CM; Wang W; Shen L; Chen ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):235-9. PubMed ID: 24749347
[TBL] [Abstract][Full Text] [Related]
18. [Protective effects and underlying mechanisms of Panax notoginseng saponins against SH-SY5Y cell apoptosis induced by 6-hydroxydopamine].
Wang MX; Zhao JY; Sun DM; Meng XB; Sun GB; Sun XB
Yao Xue Xue Bao; 2016 Jun; 51(6):898-906. PubMed ID: 29879342
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic potential of Panax notoginseng saponins (PNS): a review.
Uzayisenga R; Ayeka PA; Wang Y
Phytother Res; 2014 Apr; 28(4):510-6. PubMed ID: 23846979
[TBL] [Abstract][Full Text] [Related]
20. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion.
Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX
J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
